F. Kobayashi

Comparison of haemoconcentration induced by big endothelin‐1 and endothelin‐1 in mice

H. Okumura, N. Ashizawa, A. Matsuura, 1993, British journal of pharmacology.

Big endothelin-1-induced sudden death is inhibited by phosphoramidon in mice.

H. Okumura, N. Ashizawa, A. Matsuura, 1992, Life sciences.

Diltiazem Facilitates Endothelin Clearance from the Blood Stream to Reduce Toxic Elevation of Plasma Endothelin Level in Rodents *

H. Okumura, N. Ashizawa, A. Matsuura, 1994, The Journal of pharmacy and pharmacology.

Pharmacological profiles of aspergillomarasmines as endothelin converting enzyme inhibitors.

M. Takahashi, H. Okumura, N. Ashizawa, 1993, Japanese journal of pharmacology.

Relaxing action of okadaic acid, a black sponge toxin on the arterial smooth muscle.

N. Ashizawa, K. Nakayama, Y. Tanaka, 1989, Biochemical and biophysical research communications.

Pharmacological profiles of a novel aldose reductase inhibitor, SPR-210, and its effects on streptozotocin-induced diabetic rats.

A. Matsuura, Y. Nakamura, F. Kobayashi, 1994, Japanese journal of pharmacology.

Synthesis and inhibitory activity of isoindolinone derivatives on thromboxane A2 analog (U-46619)-induced vasocontraction.

K. Achiwa, N. Ashizawa, H. Ebiike, 1990, Chemical & pharmaceutical bulletin.

Novel and potent aldose reductase inhibitors: 4-benzyl- and 4-(benzothiazol-2-ylmethyl)-3,4-dihydro-3-oxo-2H-1,4-benzothiazine-2-ac etic acid derivatives.

T. Matsui, Y. Nakamura, T. Aotsuka, 1994, Chemical & pharmaceutical bulletin.

Possible involvement of different mechanisms in sudden death induced by endothelin-1 and big endothelin-1.

H. Okumura, N. Ashizawa, A. Matsuura, 1995, Biological & pharmaceutical bulletin.